7.37 Molecular and Engineering Aspects of Biotechnology
Covers biological and bioengineering principles underlying the development and therapeutic use of recombinant proteins and stem cells; glycoengineering of recombinant proteins; normal and pathological signaling by growth factors and their receptors; receptor trafficking; monoclonal antibodies as therapeutics; protein pharmacology and delivery; stem cell-derived tissues as therapeutics; RNA therapeutics; combinatorial protein engineering; and new antitumor drugs.
This class counts for a total of 12 credits.
You can find more information at the MIT Department of Biology: 7.37j/10441j - Molecular & Engineering Aspects of Biotechnology site or on the 7.37 Stellar site.
© Copyright 2015 Yasyf Mohamedali